Purchase now to begin learning about antidepressant tapers in preparation for psychedelic therapies! Course Features: Six on-demand content modules to watch at your own pace Resources to monitor and plan antidepressant tapers 30 day money back guarantee if you're not satisfied

Psychedelic-assisted therapy has the potential to revolutionize mental healthcare. The time for a paradigm shift in how we help those suffering from some of today’s most pervasive and difficult to treat mental health conditions is now. Learn the highly compelling evidence-based data emerging from psychedelic science in our online course, "Beyond Stigma: The Fundamentals of Psychedelic Medicine". Enroll today:

Time to complete course: 16 hours Online platform access: 6 months Continuing medical education (CME) approved for 16 AMA PRA Category 1 Credit™ For the best experience, we recommend taking the course on a tablet or computer. Go here for CE courses ($399 Psilocybin and MDMA) and regular priced courses ($199 Psilocybin and MDMA). 100% Student Satisfaction or money back guarantee

This 14-week course is a diverse and challenging set of readings aimed toward deepening each student’s understanding of psychedelic processes and their application in psychedelic integration therapy. The papers and chapters have been chosen to engage with multiple discourses relevant to this goal--academic, anthropological, indigenous/shamanic, mindfulness-based, psychoanalytic and existential--to deepen our capacity to facilitate growth and well being in the individuals who come to us for help.

Polaris Insight Center provides didactic, experiential, and residential trainings in Ketamine Assisted Therapy. These programs are designed to provide interested physicians, psychologists, therapists, nurses, and other healthcare professionals with principles and procedures of KAP and how to use ketamine in combination with psychotherapy in a clinical setting.

If you have landed on this page, it is safe to assume that you have a curiosity about the potential benefit of psychedelic substances. We understand that there has been a lot of buzz lately about the therapeutic effects of these substances and that people, like you, are becoming more interested in the topic. It is an exciting time to become interested in this topic considering the potential that these substances and medicines have for personal and spiritual development.

The goal of this group is to provide a safe, informative and confidential place for therapists and other practitioners to discuss their clinical work in psychedelic integration. This group will meet weekly for 12 weeks, and will keep the same members for the 12-week period. We will be learning the principles of Psychedelic Integration and methods for working with psychedelic experiences into ongoing psychotherapies.

This 5-day experiential retreat is designed for therapists who practice psychedelic integration or psychedelic-assisted therapy, or are training to do so. Experiential training is a component of training in which therapists experience the transformative process of the given modality themselves, and apply their insights to their own lives and to their professional work with others.

Psychedelic compounds have a rich and fascinating history of use in spiritual and healthcare settings. After a nearly 60-year hiatus, recent advances in clinical research indicate that these medicines may soon be available to the public as treatments for some of humanity’s most profound forms of suffering: alcoholism, drug addiction, PTSD, and depression. Psychotherapists and other healthcare providers are increasingly called upon to help clients integrate profoundly meaningful psychedelic experiences into the fabric of their daily lives, resulting in long-term positive changes.

Psychedelic compounds have a rich and fascinating history of use in spiritual and healthcare settings. After a nearly 60-year hiatus, recent advances in clinical research indicate that these medicines may soon be available to the public as treatments for some of humanity’s most profound forms of suffering: alcoholism, drug addiction, PTSD, and depression. Psychotherapists and other healthcare providers are increasingly called upon to help clients integrate profoundly meaningful psychedelic experiences into the fabric of their daily lives, resulting in long-term positive changes.

This 3-day training offered by psychologists Ingmar Gorman and Elizabeth Nielson is designed for clinicians and healthcare providers who want to learn more about current psychedelic research and clinical practice, including how to work with patients who have a history of psychedelic use or have expressed an interest in using psychedelics.

Exploring the Potential Use of Psychedelics for the Improvement of Persistent and Intractable Mental Health Symptoms and Implications for Nursing Practice

This reading and study group will meet weekly for 12 weeks, and maintain the same membership for the 12 week period. The group will have a syllabus with papers or chapters that participants are expected to read. The format will include a short review of a selected paper by the group leader, followed by discussion of the content and related matters. This group will not be a forum for case presentations or extended sharing, either personal or clinical.

Ketamine is a dissociative anesthetic also classified as a psychedelic. In the last decade it has become frequently sought as a treatment for depression and mood disorders. This training is designed for therapists, psychologists, physicians, and other healthcare professionals who want to better understand the basics of ketamine and how they can ensure the best clinical outcomes for patients.

Time to complete course: 16 hours Online platform access: 6 months Continuing medical education (CME) approved for 16 AMA PRA Category 1 Credit™ For the best experience, we recommend taking the course on a tablet or computer. Go here for CE courses ($399 Psilocybin and MDMA) and regular priced courses ($199 Psilocybin and MDMA). 100% Student Satisfaction or money back guarantee